Cel Sci Corporation (CVM)

[drkazmd65]

Agreed actually - at least about the 'widely adopted' requirement having to happen.

This is a ludicrous number. Multikine has to actually be widely adopted as the pre-standard of care for this to even happen.

And there's pretty much no way that CVM has the data on hand demonstrating (assuming it does demonstrate it) that Multikine is actually sufficiently effective as a cancer add-on treatment before end of 2018, more likely well into 2019.

Then they would have to get the drug approved by the FDA and get it accepted by the Medical Community as a viable add-on treatment.

That number isn't going to happen unless that all happens, but if that all does happen in reasonable time (2019-ish) it is a possibility going forward. So 'ludicrous' depends on your time scale.